AVALUN receives CE-IVD mark certification

LabPad INR got CE marked this month for patient self-testing following a conformity assessment conducted by BSI Healthcare, a UK based notified body.
 While LabPad INR was made available since December 2017 for healthcare professional only, this is a key milestone that will pave our way towards full commercial launch at the beginning of 2018, with an initial focus on the European market.
 Further tests are under development, with a focus on cardiovascular diseases application.